The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

Melodiol Q2 Revenue and Updates

by admin July 4, 2024
July 4, 2024
Melodiol Q2 Revenue and Updates

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it has delivered another strong revenue quarter. During Q2 of 2024, Melodiol generated unaudited revenue of$4.8m, a 9% increase on Q1 2024 ($4.4m). H2 2024 unaudited revenues now total $9.2m, a 31% increase on H1 2023 ($7.0m).

Highlights:

  • Q2 2024 unaudited revenues total $4.8m, a 9% increase on Q1 2024 ($4.4m)
  • Brings H1 2024 unaudited revenues to $9.2m, a 31% increase on H1 2023 ($7.0m)
  • Growth underpinned by strong results at Mernova

Growth was underpinned by strong results at Mernova. During Q2 of 2024, Mernova had confirmed unaudited purchase orders of $2.0m (C$1.8m). This figure is a 25% increase on Q1 2024 ($1.6m) and a 33% increase on Q2 2023 ($1.5m). In addition to these strong results, Mernova already has confirmed purchase orders for Q3 2024 of $452k (C$411k), providing a strong foundation for the quarter.

Additionally, Mernova achieved a variety of key objectives, including the introduction of a new product category (edibles), the approval of numerous new SKUs in existing provinces, the introduction of new vaporiser flavours and a supply agreement to source additional capacity to keep up with strong demand.

In addition to these strong results, Mernova already has confirmed purchase orders for Q3 2024 of $452k (C$411k), providing a strong foundation for the quarter.

During Q2 of 2024, HHI also provided $2.8m in sales between its Australian and UK divisions. As stated previously, the Company is committed to rationalising non-core business units, while focusing on its core divisions, Mernova and HHI in an effort to achieve profitability as quickly as possible.

Management commentary:

CEO and Managing Director, Mr William Lay said:“We are very pleased to demonstrate quarter on quarter growth for Melodiol as a group. During the last year, the Company has completed a step change in terms of revenue size, and we are sharply focused on Mernova and HHI as our core business units. By focusing on these business units, and rationalising non-core business units, all of our teams are working hard to achieve group profitability as quickly as possible.”

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Endeavour Pours First Gold at Lafigué Mine, Looks for More Côte d’Ivoire Opportunities
next post
Biden’s ex-press secretary Jen Psaki to sit down with House GOP panel probing chaotic Afghanistan withdrawal

Related Posts

Tech 5: OpenAI Restructures, Apple Pursues AI Search,...

May 11, 2025

IEF Applauds UK’s £21.7 Billion Carbon Capture Investment

October 8, 2024

How to Invest in Technology (Updated 2024)

March 9, 2024

2025 Exploration Drilling Commences at Sandstone

January 20, 2025

Holding(s) in Company

November 16, 2024

John Feneck: Gold Backdrop Looks “Amazing,” Plus 7...

April 22, 2025

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving...

May 5, 2025

Gold Price Hits New Record as Fed Holds...

March 20, 2025

Lancaster Resources

April 11, 2024

Notice of Annual General Meeting/Proxy Form

May 3, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,402)
    • Investing (3,381)
    • Politics (4,562)
    • World (4,498)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved